Irit Ben‐Aharon

5.7k total citations · 1 hit paper
108 papers, 2.9k citations indexed

About

Irit Ben‐Aharon is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Irit Ben‐Aharon has authored 108 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 27 papers in Public Health, Environmental and Occupational Health and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Irit Ben‐Aharon's work include Reproductive Biology and Fertility (23 papers), Gastric Cancer Management and Outcomes (17 papers) and Ovarian function and disorders (13 papers). Irit Ben‐Aharon is often cited by papers focused on Reproductive Biology and Fertility (23 papers), Gastric Cancer Management and Outcomes (17 papers) and Ovarian function and disorders (13 papers). Irit Ben‐Aharon collaborates with scholars based in Israel, United Kingdom and United States. Irit Ben‐Aharon's co-authors include Salomon M. Stemmer, Ruth Shalgi, Anat Gafter‐Gvili, Leonard Leibovici, Harriet MacLehose, Nigel A. Cunliffe, Karla Soares‐Weiser, Femi Pitan, Elad Goldberg and Shulamith Rizel and has published in prestigious journals such as Cell, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Irit Ben‐Aharon

106 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise—Evidence and Implications

2023 90 citations Irit Ben‐Aharon, Elisa Fontana et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Irit Ben‐Aharon Israel	29	927	767	661	537	507	108	2.9k
Hideto Yamada Japan	38	381 0.4×	1.1k 1.5×	825 1.2×	787 1.5×	583 1.1×	314	6.2k
Kevin M. Elias United States	30	761 0.8×	790 1.0×	805 1.2×	415 0.8×	245 0.5×	152	4.6k
Yan Du China	30	524 0.6×	215 0.3×	1.0k 1.5×	213 0.4×	132 0.3×	155	2.9k
Alain Berrébi France	41	256 0.3×	502 0.7×	504 0.8×	268 0.5×	582 1.1×	160	5.4k
Sophie Prévôt France	26	457 0.5×	419 0.5×	611 0.9×	115 0.2×	224 0.4×	66	3.1k
Bernard Charpentier France	40	648 0.7×	677 0.9×	804 1.2×	145 0.3×	310 0.6×	106	5.6k
Gloria Y. F. Ho United States	33	922 1.0×	308 0.4×	728 1.1×	83 0.2×	100 0.2×	67	3.9k
Inge Clemmensen Denmark	36	986 1.1×	553 0.7×	1.3k 2.0×	187 0.3×	169 0.3×	107	4.7k
William Sheridan United States	31	1.7k 1.8×	391 0.5×	565 0.9×	50 0.1×	816 1.6×	105	4.9k
Elizabeth A. Griffiths United States	33	485 0.5×	320 0.4×	1.6k 2.5×	269 0.5×	169 0.3×	151	3.5k

Countries citing papers authored by Irit Ben‐Aharon

Since Specialization

Citations

This map shows the geographic impact of Irit Ben‐Aharon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irit Ben‐Aharon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irit Ben‐Aharon more than expected).

Fields of papers citing papers by Irit Ben‐Aharon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irit Ben‐Aharon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irit Ben‐Aharon. The network helps show where Irit Ben‐Aharon may publish in the future.

Co-authorship network of co-authors of Irit Ben‐Aharon

This figure shows the co-authorship network connecting the top 25 collaborators of Irit Ben‐Aharon. A scholar is included among the top collaborators of Irit Ben‐Aharon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irit Ben‐Aharon. Irit Ben‐Aharon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Half, Elizabeth, Zohar Levi, Ajitha Mannalithara, et al.. (2024). Colorectal cancer screening at age 45 years in Israel: Cost‐effectiveness and global implications. Cancer. 130(6). 901–912. 2 indexed citations

Ben‐Aharon, Irit, Ran S. Rotem, Cheli Melzer Cohen, et al.. (2023). Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control Study. JMIR Public Health and Surveillance. 9. e50110–e50110. 4 indexed citations

Brenner, Baruch, Ayala Hubert, Sofia Man, et al.. (2023). Treatments and clinical outcomes in stage II colon cancer (CC) patients (pts) with 12-gene Oncotype DX Colon Recurrence Score assay-guided therapy: Real-world data.. Journal of Clinical Oncology. 41(16_suppl). 3620–3620.

Poley, Maria, Patricia Mora‐Raimundo, Maya Kaduri, et al.. (2022). Nanoparticles Accumulate in the Female Reproductive System during Ovulation Affecting Cancer Treatment and Fertility. ACS Nano. 16(4). 5246–5257. 23 indexed citations

Ben‐Aharon, Irit, Ayala Hubert, Deirdre Jill Cohen, et al.. (2022). 1223P First-line lenvatinib (Len) + pembrolizumab (Pembro) + chemotherapy (Chemo) vs chemo in advanced/metastatic gastroesophageal adenocarcinoma: LEAP-015 safety run-in. Annals of Oncology. 33. S1108–S1108. 4 indexed citations

Pevsner‐Fischer, Meirav, Tal Goshen‐Lago, Judith Diment, et al.. (2021). Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles. Cancer Research. 81(7). 1639–1653. 71 indexed citations

Goshen‐Lago, Tal, Moran Szwarcwort‐Cohen, Anat Reiner‐Benaim, et al.. (2021). Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid Tumors. Cancer Discovery. 11(10). 2430–2435. 37 indexed citations

Koessler, Thibaud, María Alsina, Dirk Arnold, et al.. (2021). Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group. British Journal of Cancer. 125(7). 911–919. 3 indexed citations

Ben‐Aharon, Irit, et al.. (2021). 1559O Efficacy and toxicity of BNT162b2 vaccine in cancer patients. Annals of Oncology. 32. S1130–S1130. 2 indexed citations

10.

Bar‐Joseph, Hadas, Fedro A. Peccatori, Tal Goshen‐Lago, et al.. (2020). Cancer During Pregnancy: The Role of Vascular Toxicity in Chemotherapy-Induced Placental Toxicity. Cancers. 12(5). 1277–1277. 8 indexed citations

11.

Amitay‐Laish, Iris, Ayelet Ollech, Batya B. Davidovici, et al.. (2020). Prophylactic Topical Treatment for EGFR Inhibitor-Induced Papulopustular Rash: A Randomized Clinical Trial. Dermatology. 237(6). 988–994. 3 indexed citations

12.

Stemmer, Salomon M., et al.. (2020). miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines. Frontiers in Oncology. 10. 191–191. 20 indexed citations

13.

Benedict, Catherine, et al.. (2016). Young patients and gastrointestinal (GI) tract malignancies - are we addressing the unmet needs?. BMC Cancer. 16(1). 630–630. 21 indexed citations

14.

Sulkes, Aarón, Tzippy Shochat, Daliah Tsoref, et al.. (2016). Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations. Breast Cancer Research and Treatment. 157(3). 511–516. 29 indexed citations

15.

Bar‐Joseph, Hadas, Hadas Grossman, Noa Hasky, et al.. (2015). Pigment Epithelium–Derived Factor Alleviates Tamoxifen-Induced Endometrial Hyperplasia. Molecular Cancer Therapeutics. 14(12). 2840–2849. 10 indexed citations

16.

Levi, Mattan, Ruth Shalgi, Baruch Brenner, et al.. (2015). The impact of oxaliplatin on the gonads: from bedside to the bench. Molecular Human Reproduction. 21(12). 885–893. 24 indexed citations

17.

Levi, Mattan, et al.. (2015). Dexrazoxane exacerbates doxorubicin-induced testicular toxicity. Reproduction. 150(4). 357–366. 24 indexed citations

18.

Grossman, Hadas, Mattan Levi, Ilan Tsarfaty, et al.. (2014). MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells. Oncoscience. 1(4). 250–261. 48 indexed citations

19.

Soares‐Weiser, Karla, Harriet MacLehose, Hanna Bergman, et al.. (2012). Vaccines for preventing rotavirus diarrhoea: vaccines in use (Review). LSTM Online Archive (Liverpool School of Tropical Medicine). 2 indexed citations

20.

Bar‐Joseph, Hadas, et al.. (2010). Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes. Reproductive Toxicology. 30(4). 566–572. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact